Table 1.
Patient characteristics | whole cohort N=65 |
Deficient (<20 ng/ml)
N=53 (81.5%) |
Sufficient (≥20ng/ml) N=12
(18.5%) |
P |
---|---|---|---|---|
Mean age (years) | 37.6±13.6 | 35.8±12.3 | 45.3±17.0 | 0.09 |
Median age (years, range) | 37(15-68) | 36(15-64) | 47(17-68) | |
Gender | ||||
Male n (%) | 38 | 32 (60.4) | 6 (50) | 0.51 |
Female n (%) | 27 | 21 (39.6) | 6 (50) | |
BMI (kg/m2) | 24.2 | 23.9 | 25.5 | 0.33 |
FLT3 present n (%) | 16(24.6) | 14 (26.4) | 2 (16.7) | 0.71 |
WT1 mutated present n (%) | 58 (89.2) | 47 (88.7) | 11 (91.7) | 0.99 |
Serum calcium level (mg/dL) | 8.24±0.66 | 8.24±0.64 | 8.27±0.77 | 0.54 |
Serum phosphorus level (mg/dL) | 3.68±0.80 | 3.65±0.70 | 3.78±1.17 | 0.72 |
Serum magnesium level (mg/dL) | 1.88±0.23 | 1.89±0.211 | 1.78±0.26 | 0.20 |
Serum sodium level (mg/dL) | 140.51±2.88 | 140.41±2.62 | 140.91±3.910 | 0.69 |
Serum potassium level (mg/dL) | 3.98±0.39 | 4.03±0.36 | 3.77±0.50 | 0.17 |
Serum creatinine level (mg/dL) | 0.86±0.19 | 0.85±0.19 | 0.89±0.23 | 0.58 |
Blood urea concentration (mg/dL) | 13.61±4.50 | 13.25±4.35 | 15.33±4.99 | 0.11 |
Serum Albumin level (mg/dL) | 3.69±0.46 | 3.68±0.48 | 3.75±0.37 | 0.47 |
INR | 1.22±0.19 | 1.21±0.18 | 1.26±0.23 | 0.56 |
Serum ALT level (mg/dL) | 29.12±17.24 | 29.34±18.00 | 28.16±14.05 | 0.96 |
Serum AST level (mg/dL) | 24.83±11.17 | 25.47±11.43 | 22.00±9.90 | 0.42 |
Serum ALP level (mg/dL) | 174.07±79.07 | 183.66±81.62 | 131.75±49.88 | 0.04* |
Hemoglobin g/dL | 8.57±1.79 | 8.57±1.79 | 8.53±1.89 | 0.71 |
Platelet count ×109/L | 63.13±84.48 | 51.89±44.07 | 112.83±170.41 | 0.44 |
WBC count ×109/L | 20.04±46.12 | 25.20±50.15 | 13.52±19.16 | 0.45 |
Lab data presented as mean ± Standard Deviation, 25(OH) D: 25 hydroxy vitamin D, ALT: Alanine aminotranspherase, AST: Aspartate aminotranspherase, BMI: Body mass index, ALP: Alkaline phosphatase, INR: International normalized ratio, WBC: White blood cell
Significant difference